Ekso Bionics (EKSO) Holdings entered into an agreement with Israel-based MediTouch to become the exclusive authorized sales agent and distributor of MediTouch’s BalanceTutor rehabilitation system in the United States.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EKSO:
- China Flags Humanoid Robot Bubble Risk as Investor Hype Grows
- Ekso Bionics’ Strong Q3 2025 Recovery and Strategic Prospects Lead to Buy Rating
- Ekso Bionics price target raised to $6 from $4 at H.C. Wainwright
- Ekso Bionics Announces Executive Equity Award Grants
- Ekso Bionics Announces $3.2 Million Stock Offering